Created at Source Raw Value Validated value
March 17, 2021, 12:31 a.m. usa

2-fold and 4-fold rise in neutralizing antibody titer;Fold-rise in neutralizing antibody titer;Neutralizing antibody titer;Occurrence of neutralizing antibody seroconversion;Presence of immediate adverse events;Presence of medically attended adverse events;Presence of out-of-range biological test results;Presence of serious adverse events (SAE) and adverse events of special interest (AESI);Presence of solicited injection site reactions and systemic reactions;Presence of unsolicited adverse events

2-fold and 4-fold rise in neutralizing antibody titer;Fold-rise in neutralizing antibody titer;Neutralizing antibody titer;Occurrence of neutralizing antibody seroconversion;Presence of immediate adverse events;Presence of medically attended adverse events;Presence of out-of-range biological test results;Presence of serious adverse events (SAE) and adverse events of special interest (AESI);Presence of solicited injection site reactions and systemic reactions;Presence of unsolicited adverse events